134 related articles for article (PubMed ID: 12690673)
1. [Parkinson disease: deep cerebral stimulation].
Krack P
Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S135-41. PubMed ID: 12690673
[TBL] [Abstract][Full Text] [Related]
2. [Parkinson's disease: deep brain stimulation].
Krack P
Rev Neurol (Paris); 2002; 158(122):135-141. PubMed ID: 12690324
[TBL] [Abstract][Full Text] [Related]
3. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
[TBL] [Abstract][Full Text] [Related]
4. Surgical treatment of Parkinson's disease.
Obeso JA; Rodríguez MC; Gorospe A; Guridi J; Alvarez L; Macias R
Baillieres Clin Neurol; 1997 Apr; 6(1):125-45. PubMed ID: 9426872
[TBL] [Abstract][Full Text] [Related]
5. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY
Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833
[TBL] [Abstract][Full Text] [Related]
7. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
[TBL] [Abstract][Full Text] [Related]
8. Deep brain stimulation for Parkinson's disease: surgical technique and perioperative management.
Machado A; Rezai AR; Kopell BH; Gross RE; Sharan AD; Benabid AL
Mov Disord; 2006 Jun; 21 Suppl 14():S247-58. PubMed ID: 16810722
[TBL] [Abstract][Full Text] [Related]
9. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of the subthalamic nucleus in a patient with Parkinson disease and essential tremor.
Stover NP; Okun MS; Evatt ML; Raju DV; Bakay RA; Vitek JL
Arch Neurol; 2005 Jan; 62(1):141-3. PubMed ID: 15642861
[TBL] [Abstract][Full Text] [Related]
11. Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease.
Piboolnurak P; Lang AE; Lozano AM; Miyasaki JM; Saint-Cyr JA; Poon YY; Hutchison WD; Dostrovsky JO; Moro E
Mov Disord; 2007 May; 22(7):990-7. PubMed ID: 17443692
[TBL] [Abstract][Full Text] [Related]
12. The role of deep brain stimulation as a surgical treatment for Parkinson's disease.
Olanow CW; Brin MF; Obeso JA
Neurology; 2000; 55(12 Suppl 6):S60-6. PubMed ID: 11188977
[TBL] [Abstract][Full Text] [Related]
13. Deep brain stimulation.
Breit S; Schulz JB; Benabid AL
Cell Tissue Res; 2004 Oct; 318(1):275-88. PubMed ID: 15322914
[TBL] [Abstract][Full Text] [Related]
14. Subthalamic stimulation in Parkinson disease: intraoperative predictive factors.
Houeto JL; Welter ML; Bejjani PB; Tezenas du Montcel S; Bonnet AM; Mesnage V; Navarro S; Pidoux B; Dormont D; Cornu P; Agid Y
Arch Neurol; 2003 May; 60(5):690-4. PubMed ID: 12756132
[TBL] [Abstract][Full Text] [Related]
15. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
Yamada K; Goto S; Hamasaki T; Kuratsu JI
Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
[TBL] [Abstract][Full Text] [Related]
16. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
Herzog J; Möller B; Witt K; Pinsker MO; Deuschl G; Volkmann J
Mov Disord; 2009 Jun; 24(8):1206-10. PubMed ID: 19412937
[TBL] [Abstract][Full Text] [Related]
17. Subthalamic nucleus stimulation in Parkinson's disease patients intolerant to levodopa.
Lyons KE; Davis JT; Pahwa R
Stereotact Funct Neurosurg; 2007; 85(4):169-74. PubMed ID: 17259749
[TBL] [Abstract][Full Text] [Related]
18. Subthalamic nucleus stimulation in Parkinson's disease: postoperative CT-MRI fusion images confirm accuracy of electrode placement using intraoperative multi-unit recording.
Shin M; Lefaucheur JP; Penholate MF; Brugières P; Gurruchaga JM; Nguyen JP
Neurophysiol Clin; 2007 Dec; 37(6):457-66. PubMed ID: 18083502
[TBL] [Abstract][Full Text] [Related]
19. Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
Kim HJ; Paek SH; Kim JY; Lee JY; Lim YH; Kim DG; Jeon BS
Mov Disord; 2009 Feb; 24(3):329-35. PubMed ID: 19006187
[TBL] [Abstract][Full Text] [Related]
20. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
